Islet Cell Tumor Clinical Trials Updates During the Last 45 Dayshttp://www.clinicaltrialsfeeds.org/clinical-trials/results/term=Islet+Cell+TumorClinical trials database search returned results for the query Islet Cell Tumor AND ( "12/31/2011" : MAX ) [LAST-RELEASE-DATE].Tue, 14 Feb 2012 10:11:58 GMTCapecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumorshttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01525082http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01525082Status: Not yet recruiting, Condition Summary: Gastrinoma; Glucagonoma; Insulinoma; Pancreatic Polypeptide Tumor; Recurrent Islet Cell Carcinoma; Recurrent Pancreatic Cancer; Somatostatinoma; Stage III Pancreatic Cancer; Stage IV Pancreatic CancerWed, 01 Feb 2012 05:00:00 GMTA Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumorshttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01525550http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01525550Status: Not yet recruiting, Condition Summary: Well-differentiated Pancreatic Neuroendocrine TumorTue, 31 Jan 2012 05:00:00 GMTEfficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumorshttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01121562http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01121562Status: Active, not recruiting, Condition Summary: Pancreatic Neuroendocrine TumorsSun, 15 Jan 2012 05:00:00 GMTTemsirolimus and Bevacizumab in Treating Patients With Locally Advanced, Recurrent, Metastatic, or Progressive Endometrial Cancer, Ovarian Epithelial Cancer, Liver Cancer, Islet Cell Cancer, or Carcinoid Tumorhttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01010126http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01010126Status: Recruiting, Condition Summary: Endometrial Cancer; Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Liver Cancer; Lung Cancer; Ovarian CancerThu, 02 Feb 2012 05:00:00 GMTTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumorshttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01155258http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01155258Status: Active, not recruiting, Condition Summary: Extensive Stage Small Cell Lung Cancer; Hereditary Paraganglioma; Male Breast Cancer; Malignant Paraganglioma; Metastatic Gastrointestinal Carcinoid Tumor; Metastatic Pheochromocytoma; Pancreatic Polypeptide Tumor; Recurrent Breast Cancer; Recurrent Cervical Cancer; Recurrent Endometrial Carcinoma; Recurrent Gastrointestinal Carcinoid Tumor; Recurrent Islet Cell Carcinoma; Recurrent Neuroendocrine Carcinoma of the Skin; Recurrent Non-small Cell Lung Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Recurrent Pheochromocytoma; Recurrent Prostate Cancer; Recurrent Renal Cell Cancer; Recurrent Small Cell Lung Cancer; Recurrent Uterine Sarcoma; Regional Gastrointestinal Carcinoid Tumor; Regional Pheochromocytoma; Stage III Cervical Cancer; Stage III Endometrial Carcinoma; Stage III Neuroendocrine Carcinoma of the Skin; Stage III Ovarian Epithelial Cancer; Stage III Ovarian Germ Cell Tumor; Stage III Prostate Cancer; Stage III Renal Cell Cancer; Stage III Uterine Sarcoma; Stage IIIA Breast Cancer; Stage IIIA Non-small Cell Lung Cancer; Stage IIIB Breast Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer; Stage IV Endometrial Carcinoma; Stage IV Neuroendocrine Carcinoma of the Skin; Stage IV Non-small Cell Lung Cancer; Stage IV Ovarian Epithelial Cancer; Stage IV Ovarian Germ Cell Tumor; Stage IV Prostate Cancer; Stage IV Renal Cell Cancer; Stage IV Uterine Sarcoma; Stage IVA Cervical Cancer; Stage IVB Cervical Cancer; Thyroid Gland Medullary CarcinomaWed, 01 Feb 2012 05:00:00 GMTA Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00428220http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00428220Status: Recruiting, Condition Summary: Metastatic Breast Cancer; Advanced Breast Cancer; Gastrointestinal Stromal Tumor; Hepatocellular Carcinoma; Metastasizing Breast Cancer (F); Metastatic Castration-Resistant Prostate Cancer; Metastatic Renal Cell Cancer; Non Small Cell Lung Cancer; Pancreatic Islet Cell CarcinomaMon, 06 Feb 2012 05:00:00 GMT68Ga-DOTATATE PET Scan in Neuroendocrine Cancerhttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01396382http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01396382Status: Recruiting, Condition Summary: Neuroendocrine CarcinomaTue, 17 Jan 2012 05:00:00 GMTEfficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumorshttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00510068http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00510068Status: Active, not recruiting, Condition Summary: Advanced Neuroendocrine TumorsFri, 10 Feb 2012 05:00:00 GMTPazopanib as Single Agent in Advanced NETshttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01280201http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01280201Status: Recruiting, Condition Summary: Advanced/Metastatic Neuroendocrine TumorsThu, 19 Jan 2012 05:00:00 GMTSwissNET - a Registry for Neuroendocrine Tumours in Switzerlandhttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01039922http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01039922Status: Recruiting, Condition Summary: Neuroendocrine Tumors; Carcinoid TumorMon, 16 Jan 2012 05:00:00 GMT